14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.41 $2.35 Thursday, 25th Apr 2024 CYCC stock ended at $1.60. This is 30.43% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 40.93% from a day low at $1.41 to a day high of $1.99.
90 days $1.41 $3.08
52 weeks $1.41 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Mar 26, 2021 $7.47 $7.59 $7.06 $7.40 118 533
Mar 25, 2021 $7.14 $7.53 $6.91 $7.43 263 563
Mar 24, 2021 $7.78 $7.85 $7.20 $7.23 92 168
Mar 23, 2021 $7.98 $8.02 $7.55 $7.73 113 645
Mar 22, 2021 $8.35 $8.49 $7.84 $7.96 117 892
Mar 19, 2021 $8.20 $8.59 $8.00 $8.39 258 355
Mar 18, 2021 $8.38 $8.63 $8.00 $8.15 180 084
Mar 17, 2021 $7.91 $8.61 $7.91 $8.34 156 632
Mar 16, 2021 $8.78 $8.78 $7.85 $8.26 500 867
Mar 15, 2021 $7.43 $8.95 $7.43 $8.69 1 232 052
Mar 12, 2021 $7.34 $7.94 $7.22 $7.55 1 226 076
Mar 11, 2021 $7.22 $8.00 $7.17 $7.87 930 864
Mar 10, 2021 $7.40 $7.48 $6.85 $7.21 436 722
Mar 09, 2021 $6.15 $7.66 $6.15 $7.21 1 073 799
Mar 08, 2021 $6.32 $6.54 $5.90 $6.05 378 379
Mar 05, 2021 $6.05 $6.29 $5.54 $6.17 315 758
Mar 04, 2021 $6.75 $6.89 $5.71 $6.10 615 033
Mar 03, 2021 $7.45 $7.63 $6.55 $6.76 520 329
Mar 02, 2021 $7.41 $7.88 $7.28 $7.37 187 842
Mar 01, 2021 $7.09 $7.67 $6.92 $7.47 385 246
Feb 26, 2021 $7.13 $7.15 $6.45 $6.90 396 001
Feb 25, 2021 $7.34 $7.89 $6.95 $7.00 517 475
Feb 24, 2021 $7.31 $7.65 $7.09 $7.41 568 936
Feb 23, 2021 $7.46 $7.53 $6.31 $7.26 880 824
Feb 22, 2021 $8.38 $8.45 $7.60 $7.76 362 400
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT